5 questions for: Theravance CEO Rick Winningham

Theravance begins a new chapter on 15 May when it splits into two companies known as Theravance Royalty Management and Theravance Biopharma – the former charged with collecting cash from the sale of respiratory medicines partnered with GlaxoSmithKline and the latter focused on research and development.